跳至主要内容
临床试验/NCT02113683
NCT02113683终止不适用

Validation of MMS Test to Detect Active Tumor Growth of Different Cancer Types Before and After Therapy, as Well as for Subsequent Relapse Control in Comparison to Conventional Methods

MedInnovation GmbH1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2014年5月最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
100
试验地点
1
主要终点
active tumor growth before and after cancer therapy

研究概览

简要总结

The purpose of this study is the validation of MMS test to detect active tumor growth in different cancer types before and after therapy, as well as in the course of therapy and for subsequent relapse control compared to standard methods (clinical examination, imaging, tumor markers). It should be consider whether the MMS test has comparable diagnostic accuracy, and thus can replace more expensive or invasive procedures in future.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Clinical diagnosis of colo-rectal cancer
  • Clinical diagnosis of stomach cancer
  • Suspected diagnosis of melanoma

排除标准

  • Colitis ulcerosa
  • Morbus Crohn
  • Cancer in time period two years before
  • Cancer therapy in time period two years before

结局指标

主要结局

active tumor growth before and after cancer therapy

时间窗: up to 36 month

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验